Give 15% off, earn 10% back on every order they place.
Research-grade compound. Laboratory use only. Not intended for human or animal use, ingestion, or injection. No medical claims are made or implied.

Delivers to EU in 11-14 business days
Free shipping over €200 · no customs paperwork (EU) · via EU carrier network
Tirzepatide 10mg + Bacteriostatic Water 5ml + 2 x 3ml syringes + 5 x 1ml insulin syringes. Everything you need to begin research. For research purposes only. Bundle price: save EUR 25.97 vs buying the peptide, bacteriostatic water and syringe packs separately (about EUR 79.96 on their own).
| Quantity | Price Each | Total | Savings |
|---|---|---|---|
| 1 unit | €53.99 | €53.99 | -- |
| 3+ | €51.29 | €153.87 | 5% off |
| 5+Most Popular | €48.59 | €242.96 | 10% off |
| 10+ | €45.89 | €458.92 | 15% off |
Free shipping on orders over €200
Important Notice
This product is intended for laboratory and research use only. Not for human or veterinary use. By purchasing, you confirm this product will be used exclusively for in-vitro research purposes.
Reconstitution Required
This peptide ships lyophilized (dry powder) and requires bacteriostatic water to reconstitute before use. BAC water is sold separately.
Recommended: BAC water · stable for 28 days at 2-8°C once mixed.
99.3% average HPLC purity, verified by independent third-party testing
Janoshik report published when available
24h dispatch, EU-wide shipping from €4.99
Supplier batch specification on every product; independent Janoshik report on selected lots
The Tirzepatide Research Starter Kit provides research-grade tirzepatide with reconstitution supplies for laboratory use. Tirzepatide (LY3298176) is a dual GIP and GLP-1 receptor agonist designed to co-activate both class B GPCR receptor subtypes from a single 39-amino-acid hybrid scaffold. Understanding the pharmacology of dual-receptor agonism has driven substantial academic in vitro research into the GIP receptor's role in metabolic signalling.
For years, GIP was considered a questionable target for metabolic research because GIP receptor knockout mice were protected from diet-induced phenotype changes while GIP receptor agonism alone produced modest or even pro-adipogenic effects in some studies. Recent receptor-pharmacology results have forced a re-evaluation: the combination of GIP and GLP-1 receptor co-agonism appears to produce synergistic effects on receptor signalling and energy-balance markers in animal models that neither receptor achieves alone. The mechanistic explanation is still developing -- some researchers favour a central nervous system co-signalling model, others emphasise peripheral adipose and pancreatic in vitro effects.
Research uses include comparative receptor pharmacology, receptor subtype attribution studies via knockout models, islet biology, adipocyte differentiation, and CNS satiety circuit mapping. The starter kit format makes it practical to begin pilot in vitro experiments without committing to large quantities before establishing working concentrations.
| Component | Quantity | Details |
|---|---|---|
| Tirzepatide | 1 x 10mg | ≥98% supplier batch spec (99.3% avg across independently tested lots), lyophilized |
| Bacteriostatic Water | 1 x 5ml | Sterile, 0.9% benzyl alcohol |
| 3ml Syringes | 2 | For reconstitution and draw-up |
| 1ml Insulin Syringes | 5 | For precision dosing of research subjects in laboratory protocols |
Store lyophilized peptide at -20°C. Reconstitute with bacteriostatic water to your working concentration. Stable at 4°C for 28-30 days post-reconstitution. The fatty acid C18 chain (which provides albumin binding for extended in vitro stability) makes the solution slightly viscous at higher concentrations -- this is normal and does not indicate degradation. Allow to reach room temperature before drawing into pipette for more accurate small-volume dosing.
Semaglutide is a GLP-1 analogue with a modified sequence closely based on native GLP-1, extended with a C18 fatty diacid chain for albumin binding. Tirzepatide uses a different backbone -- a 39-amino-acid hybrid peptide with a GIP-derived sequence engineered to co-activate both GIP and GLP-1 receptors. The two receptors belong to the same class B GPCR family but differ enough in their binding pockets that achieving dual agonism required a novel scaffold rather than simple modification of an existing agonist.
cAMP accumulation assays in CHO or HEK293 cells stably expressing each receptor are the standard. Radioligand binding displacement with [125I]-GIP or [125I]-GLP-1 characterises binding affinity. Beta-arrestin recruitment assays (HTRF or BRET-based) characterise biased agonism. For functional readouts in pancreatic islets, glucose-stimulated insulin secretion (GSIS) at multiple glucose concentrations is the classic in vitro assay. Note that GIP receptor responses differ between human and rodent tissue -- rat and mouse GIP receptors have different pharmacology from the human receptor, a known translational gap worth flagging in study design.
Tirzepatide Research Starter Kit is supplied for laboratory research use only. Not for human or veterinary use. For research purposes only.
Researcher Confidence
Who actually tests this?
Selected lots are independently verified by Janoshik Analytical (Czech Republic) and published on the Janoshik public portal. Other lots ship with the supplier's batch specification. See /coa for the published wall.
View COAs →What if I get the wrong batch?
Every bottle label carries a lot number that maps to a specific Certificate of Analysis. If a batch fails spec, we don't ship it — full stop.
View COAs →Where does it ship from?
Romania (EU). We are CERTALAB SRL, CUI 54169956, VAT-registered. Sameday for Romania, TCE Worldwide for all cross-border EU and non-EU markets (UK, Switzerland, Norway, Iceland, Israel, Serbia). Delivery 1–14 business days depending on destination — exact window shown at checkout.
Shipping details →What if there's a problem?
You have a 14-day withdrawal right under OUG 34/2014 (Romanian/EU consumer law), with ANPC/ODR escalation available. Contact us at support@certapeptides.com.
Returns policy →This product is intended for scientific research and development purposes only. It is a chemical substance that shall not be used as a drug, medicine, active substance, or ingredient in any product intended for human or animal consumption. Researchers must handle this compound in accordance with their institutional biosafety guidelines. Use only in properly equipped laboratory settings with appropriate personal protective equipment.
SAME FIELDRetatrutide 10mg + Bacteriostatic Water 5ml + 2 x 3ml syringes + 5 x 1ml insulin syringes. Everything you need to begin research. For research purposes only. Bundle price: save EUR 27.47 vs buying the peptide, bacteriostatic water and syringe packs separately (about EUR 106.46 on their own).
SAME FIELDResearch-grade Liraglutide. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
10mgSAME FIELDResearch-grade Retatrutide + Cagrilintide Blend. ≥ 98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
SAME FIELDRetatrutide is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This multi-receptor approach has generated significant research interest in metabolic studies. Triple hormone receptor agonism (GIP/GLP-1/Glucagon) Metabolic pathway modulation research Energy homeostasis and body composition studies For research purposes only.